Publications: | A Guide to the Clinical Care of Women with HIV/AIDS, 2005 edition |
Immune Category | <12 Mo | 5 Yr | <6-12 Yr | |||
---|---|---|---|---|---|---|
CD4/mm3 | % | CD4/mm3 | % | CD4/mm3 | % | |
Category 1: no suppression | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Category 2: moderate suppression | 750–1499 | 15%–24% | 500–999 | 15%–24% | 200–499 | 15%–24% |
Category 3: severe suppression | <750 | <15% | <500 | <15% | <200 | <15% |
Clinical Category | Children < 13 Yr | |||||
---|---|---|---|---|---|---|
Category N: not symptomatic | Children who have no signs or symptoms considered to be the result of HIV infection or who have only one of the conditions listed in category A. | |||||
Category A: mildly symptomatic | Children with 2 or more of the following conditions but none of the conditions listed in categories B and C:
|
|||||
Category B: moderately symptomatic | Children who have symptomatic conditions, other than those listed for category A or category C, that are attributed to HIV infection. Examples of conditions in clinical category B include, but are not limited to, the following:
|
|||||
Category C: severely symptomatic | Children who have any condition listed in the 1987 surveillance case definition for acquired immunodeficiency syndrome, with the exception of LIP (which is a category B condition) |